http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110196328-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_61c88792ba37ba7ccc97e25128cb7d6c |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57407 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate | 2019-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3244ea7eee9bec043e1c87efb1a8ac0d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c7782e8da9237f2174a9b84bb623c3c9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d7cfce58d5a4e0137186cb783d257fd2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c812e548c160bc6983d7da73d65a8f97 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a7904198c01ddd260de93d47c30c96a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e8e64ac31f2482eccea3dcf5188ee1e1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e372db683d84215e17a96f7e32f95ecd |
| publicationDate | 2019-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-110196328-A |
| titleOfInvention | Application and its kit of one group of tumor associated antigen in cancer of the esophagus early screening kit |
| abstract | The invention belongs to oncomolecularbiology fields, and in particular to application and its kit of one group of tumor associated antigen in cancer of the esophagus early screening kit.Kit of the present invention includes solid phase carrier and the cancer of the esophagus tumor associated antigen that is coated on solid phase carrier, and the cancer of the esophagus tumor associated antigen is CP96 gene expression object, CRP78 gene expression object, MMP-10 gene expression object, cav-1 gene expression object, CDC25B gene expression object, PGK1 gene expression object and HSP105 gene expression object；The kit further includes the secondary antibody of phycoerythrin conjugation.Kit of the present invention is up to 96.1% and 95.1% to the detection specificity and sensibility of the cancer of the esophagus respectively；Also, compared with organizing biopsy, kit of the present invention need to only acquire the blood of crowd to be checked, so that it may which its risk for suffering from the cancer of the esophagus of screening, wound is small, Small side effects, and easy to use, has good potential applicability in clinical practice. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111323586-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111077312-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111077312-A |
| priorityDate | 2019-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 76.